EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data

Fehime Erdem Karapınar iD, Havva Yazıcı iD, Merve Yoldaş Çelik, Ayşe Yüksel Yanbolu, Cenk Eraslan, Asude Durmaz, Ayça Aykut, Ebru Canda, Zülal Ülger Tutar, Sema Kalkan Uçar, Ertürk Levent, Eser Yıldırım Sözmen und 1 weitere

Neuropediatrics · 01.04.2026 · 57 (02) · 121-130

DOI: 10.1055/a-2777-2932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.04.2026. Verfasst von Fehime Erdem Karapınar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Inborn Error of Metabolism and Nutrition, Department of Pediatrics, Ege University Medical Faculty, Izmir, Türkiye. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Enzyme Replacement Therapy. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pompe disease is a rare lysosomal storage disorder with a wide clinical spectrum ranging from infantile-onset Pompe disease (IOPD) with early severe cardiomyopathy to late-onset Pompe disease (LOPD) with progressive muscle weakness. This study aimed to evaluate clinical features, genotype–phenotype correlations, treatment outcomes, and significant events in a real-life pediatric cohort of Pompe patients. We retrospectively analyzed 30 pediatric patients diagnosed with Pompe disease (27 IOPD, 3 LOPD). Demographic, clinical, biochemical, genetic, and radiologic data were collected. Recurrent clinical events were assessed using the Andersen-Gill extension of the Cox model to evaluate the effect of enzyme replacement therapy (ERT). The median age at diagnosis was 5 (range 20 days to 80 months) months, and consanguinity was present in 83% of cases. IOPD cases predominantly showed hypotonia and cardiac involvement, whereas LOPD cases were asymptomatic or mildly symptomatic, with delayed motor development and increased CK levels. Novel GAA mutations were identified in seven patients. ERT was administered to 24 IOPD patients, leading to improved cardiac function and prolonged survival. Event incidence was significantly lower in the ERT group (HR = 0.06, p < 0.005), despite a longer follow-up. However, 56% of patients—all with IOPD—died during follow-up. Non-muscular findings such as neurogenic bladder in 6.6% (2/30), sensorineural hearing loss in 13.3% (4/30), and white matter abnormalities in 40.9% (9/21) were also documented. This real-life evidence reinforces the central role of early, individualized ERT and comprehensive multidisciplinary care in altering the natural course of Pompe disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IIEnzyme Replacement TherapyHumansMaleFemaleInfantChild, PreschoolRetrospective StudiesChildInfant, Newbornalpha-Glucosidases

Substanzen

alpha-GlucosidasesGAA protein, human

Autor:innen und Institutionen

  • Division of Inborn Error of Metabolism and Nutrition, Department of Pediatrics, Ege University Medical Faculty, Izmir, Türkiye.
  • Department Radiology, Ege University Medical Faculty, Izmir, Türkiye.
  • Department of Medical Genetics, Ege University Medical Faculty, Izmir, Türkiye.
  • Division of Cardiology, Department of Pediatrics, Ege University Medical Faculty, Izmir, Türkiye.
  • Department of Medical Biochemistry, Ege University Medical Faculty, Izmir, Türkiye.

ORCID-Profile: Fehime Erdem Karapınar, Havva Yazıcı

Zitieren

APA

Erdem Karapınar, F., Yazıcı, H., Yoldaş Çelik, M., Yüksel Yanbolu, A., Eraslan, C., Durmaz, A., Aykut, A., Canda, E., Ülger Tutar, Z., Uçar, S. K., Levent, E., Yıldırım Sözmen, E., & Çoker, M. (2026). Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data. Neuropediatrics, 57(02), 121-130. https://doi.org/10.1055/a-2777-2932

Vancouver

Erdem Karapınar F, Yazıcı H, Yoldaş Çelik M, Yüksel Yanbolu A, Eraslan C, Durmaz A, et al. Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data. Neuropediatrics. 2026;57(02):121-130. doi:10.1055/a-2777-2932

BibTeX
@article{ErdemKarapnar2026,
  author = {Erdem Karapınar, Fehime and Yazıcı, Havva and Yoldaş Çelik, Merve and Yüksel Yanbolu, Ayşe and Eraslan, Cenk and Durmaz, Asude and Aykut, Ayça and Canda, Ebru and Ülger Tutar, Zülal and Uçar, Sema Kalkan and Levent, Ertürk and Yıldırım Sözmen, Eser and Çoker, Mahmut},
  title = {Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data},
  journal = {Neuropediatrics},
  year = {2026},
  volume = {57},
  number = {02},
  pages = {121--130},
  doi = {10.1055/a-2777-2932}
}
Kostenlos starten →